Published on in Vol 22, No 5 (2020): May

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/16084, first published .
A User-Friendly, Web-Based Integrative Tool (ESurv) for Survival Analysis: Development and Validation Study

A User-Friendly, Web-Based Integrative Tool (ESurv) for Survival Analysis: Development and Validation Study

A User-Friendly, Web-Based Integrative Tool (ESurv) for Survival Analysis: Development and Validation Study

Journals

  1. Kim K, Ko Y, Ko D, Kim Y, Shi W. Prognostic Significance of COVID-19 Receptor ACE2 and Recommendation for Antihypertensive Drug in Renal Cell Carcinoma. BioMed Research International 2020;2020:1 View
  2. Yan N, Liu C, Tian F, Wang L, Wang Y, Yang Z, Jiao Y, He M, Kurabayashi A. Downregulated mRNA Expression of ZNF385B Is an Independent Predictor of Breast Cancer. International Journal of Genomics 2021;2021:1 View
  3. Zhao Y, Tao Z, Chen X. A Three-Metabolic-Genes Risk Score Model Predicts Overall Survival in Clear Cell Renal Cell Carcinoma Patients. Frontiers in Oncology 2020;10 View
  4. Kwon E, Ha M, Jang J, Kim Y, Sandri-Goldin R. Identification and Complete Validation of Prognostic Gene Signatures for Human Papillomavirus-Associated Cancers: Integrated Approach Covering Different Anatomical Locations. Journal of Virology 2021;95(6) View
  5. Deng F, Mu J, Qu C, Yang F, Liu X, Zeng X, Peng X. A Novel Prognostic Model of Endometrial Carcinoma Based on Clinical Variables and Oncogenomic Gene Signature. Frontiers in Molecular Biosciences 2021;7 View
  6. Kim Y, Kang J, Kang J, Kwon E, Ha M, Kim Y, Lee H, Rhee J, Kim Y. Novel deep learning-based survival prediction for oral cancer by analyzing tumor-infiltrating lymphocyte profiles through CIBERSORT. OncoImmunology 2021;10(1) View
  7. Xu W, Chen Z, Liu G, Dai Y, Xu X, Ma D, Liu L, Vanden Heuvel J. Identification of a Potential PPAR-Related Multigene Signature Predicting Prognosis of Patients with Hepatocellular Carcinoma. PPAR Research 2021;2021:1 View
  8. Li Y, Li F, Bai X, Li Y, Ni C, Zhao X, Zhang D. ITGA3 Is Associated With Immune Cell Infiltration and Serves as a Favorable Prognostic Biomarker for Breast Cancer. Frontiers in Oncology 2021;11 View
  9. Zhang Q, Feng Z, Zhang Y, Shi S, Zhang Y, Ren S, Chiba T. Identification and Verification of a 17 Immune-Related Gene Pair Prognostic Signature for Colon Cancer. BioMed Research International 2021;2021:1 View
  10. Lánczky A, Győrffy B. Web-Based Survival Analysis Tool Tailored for Medical Research (KMplot): Development and Implementation. Journal of Medical Internet Research 2021;23(7):e27633 View
  11. Zhao X, He Y, Wu Y, Liu T, Wang G. IOFS-SA: An interactive online feature selection tool for survival analysis. Computers in Biology and Medicine 2022;150:106121 View
  12. Du Q, Zhou R, Wang H, Li Q, Yan Q, Dang W, Guo J. A metabolism-related gene signature for predicting the prognosis in thyroid carcinoma. Frontiers in Genetics 2023;13 View
  13. Woo S, Lee H, Park S, Choi H, Kim J, Kwon M, Sohn J, Nam J, Kim H, Song P, Baryawno N, Kim Y, Kim K, Lee D. Role of reactive oxygen species in regulating 27-hydroxycholesterol-induced apoptosis of hematopoietic progenitor cells and myeloid cell lines. Cell Death & Disease 2022;13(10) View
  14. Zou Y, Jiang G, Xie Y, Li H, Srinivasan K. m6A-Related Genes Contribute to Poor Prognosis of Hepatocellular Carcinoma. Computational and Mathematical Methods in Medicine 2022;2022:1 View
  15. Guo H, Jiang S, Sun H, Shi B, Li Y, Zhou N, Zhang D, Guo H, Tharmalingam J. Identification of IL20RB as a Novel Prognostic and Therapeutic Biomarker in Clear Cell Renal Cell Carcinoma. Disease Markers 2022;2022:1 View
  16. Wang L, Xue Y, Lou Y. Tumor-associated macrophages related signature in glioma. Aging 2022;14(6):2720 View
  17. Fang L, Chen S, Gong H, Xia S, Guan S, Quan N, Li Y, Zeng C, Chen Y, Du J, Liu S. Identification of an unfolded protein response-related signature for predicting the prognosis of pancreatic ductal adenocarcinoma. Frontiers in Oncology 2023;12 View
  18. Wei Y, Yang C, Wei Z, Liao X, He Y, Zhou X, Huang H, Lan C, Han C, Peng T. High-Mobility Group AT-Hook 1 Served as a Prognosis Biomarker and Associated with Immune Infiltrate in Hepatocellular Carcinoma. International Journal of General Medicine 2022;Volume 15:609 View
  19. Dwivedi B, Mumme H, Satpathy S, Bhasin S, Bhasin M. Survival Genie, a web platform for survival analysis across pediatric and adult cancers. Scientific Reports 2022;12(1) View
  20. Yu Y, Sung S, Lee C, Ha M, Kang J, Kwon E, Kang J, Kim Y, Kim G, Heo H, Lee H, Kim T, Lee Y, Myung K, Oh C, Kim Y. SOCS3 is Related to Cell Proliferation in Neuronal Tissue: An Integrated Analysis of Bioinformatics and Experiments. Frontiers in Genetics 2021;12 View
  21. Shin H, Gil M, Lee I. Association of Elevated Expression Levels of COL4A1 in Stromal Cells with an Immunosuppressive Tumor Microenvironment in Low-Grade Glioma, Pancreatic Adenocarcinoma, Skin Cutaneous Melanoma, and Stomach Adenocarcinoma. Journal of Personalized Medicine 2022;12(4):534 View
  22. Wu G, Li J, Xu Y, Che X, Chen F, Wang Q, Pandurangan A. A New Survival Model Based on ADAMTSs for Prognostic Prediction in Clear Cell Renal Cell Carcinoma. Journal of Oncology 2021;2021:1 View
  23. Woo S, Kim S, Seo S, Kim S, Park J, Kim G, Choi Y, Hur K, Kwon T. Inhibition of USP1 enhances anticancer drugs-induced cancer cell death through downregulation of survivin and miR-216a-5p-mediated upregulation of DR5. Cell Death & Disease 2022;13(9) View
  24. Dai L, Han Y, Yang Z, Zeng Y, Liang W, Shi Z, Tao Y, Liang X, Liu W, Zhou S, Xing Z, Hu W, Wang X. Identification and validation of SOCS1/2/3/4 as potential prognostic biomarkers and correlate with immune infiltration in glioblastoma. Journal of Cellular and Molecular Medicine 2023;27(15):2194 View
  25. Ma Y, Sun Y, Zhao X, Li J, Fu X, Gong T, Zhang X. Identification of m5C-related lncRNAs signature to predict prognosis and therapeutic responses in esophageal squamous cell carcinoma patients. Scientific Reports 2023;13(1) View
  26. Wang S, Bai H, Fei S, Miao B. A Cuproptosis-Related LncRNA Risk Model for Predicting Prognosis and Immunotherapeutic Efficacy in Patients with Hepatocellular Carcinoma. Biochemical Genetics 2023 View
  27. Jiang Y, Wei S, Koo J, Kim H, Park W, Zhang Y, Guo H, Ha K, Oh C, Kang J, Jeong J, Ryu D, Kim K, Jo Y. Integrative Evaluation of the Clinical Significance Underlying Protein Arginine Methyltransferases in Hepatocellular Carcinoma. Cancers 2023;15(16):4183 View
  28. Xu Q, Ying H, Xie C, Lin R, Huang Y, Zhu R, Liao Y, Zeng Y, Yu F. Characterization of neutrophil extracellular traps related gene pair for predicting prognosis in hepatocellular carcinoma. The Journal of Gene Medicine 2023;25(11) View
  29. Zhao Y, Liang X, Duan X, Zhang C. Exploring the prognostic function of TMB-related prognostic signature in patients with colon cancer. BMC Medical Genomics 2023;16(1) View
  30. Obermayer A, Chang D, Nobles G, Teng M, Tan A, Wang X, Chen Y, Eschrich S, Rodriguez P, Grass G, Meshinchi S, Tarhini A, Chen D, Shaw T. PATH-SURVEYOR: pathway level survival enquiry for immuno-oncology and drug repurposing. BMC Bioinformatics 2023;24(1) View
  31. Li Y, Dong Y, Xu C, Su G, Xiao L, Liu Y, Mei H. Clinical neutrophil-related gene helps treat bladder urothelial carcinoma. Oncologie 2023;25(5):529 View
  32. Li X, Xu C, Min Y, Zhai Z, Zhu Y. A prognostic signature for lung adenocarcinoma by five genes associated with chemotherapy in lung adenocarcinoma. The Clinical Respiratory Journal 2023;17(12):1349 View
  33. Kang J, Jiang J, Xiang X, Zhang Y, Tang J, Li L. Identification of a new gene signature for prognostic evaluation in cervical cancer: based on cuproptosis-associated angiogenesis and multi-omics analysis. Cancer Cell International 2024;24(1) View
  34. Chen B, Han Y, Sheng S, Deng J, Vasquez E, Yau V, Meng M, Sun C, Wang T, Wang Y, Sheng M, Wu T, Wang X, Liu Y, Lin N, Zhang L, Shao W. An angiogenesis-associated gene-based signature predicting prognosis and immunotherapy efficacy of head and neck squamous cell carcinoma patients. Journal of Cancer Research and Clinical Oncology 2024;150(2) View